GLP-1 receptor agonist
GLP-1 receptor agonist

€50 Million Boost for GLP-1 Production in France!
BIOT
🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀

Revolutionary Partnership Targets $80bn Obesity Treatment Market
BIOT
🗞️ British companies Arecor Therapeutics and TRx Biosciences partner to develop an oral GLP-1 receptor agonist for obesity treatment. 🍔🍟💊💰💡





